Thursday, June 11, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 56 of 1,261
  1. WO 2025052303

    ARN CIRCULAIRE ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS

    BEIGENE SWITZERLAND GMBH [CH] · Granted Mar 13, 2025 · Expires Mar 8, 2045

    granted
  2. WO 2025051711

    TRAITEMENT PAR PTH D'UNE MALADIE RÉNALE CHRONIQUE

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Mar 13, 2025 · Expires Mar 8, 2045

    granted
  3. US 12246023

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  4. US 12246047

    Adeno-associated virus purification methods

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  5. US 12246056

    Compositions and methods for the production of cysteine

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  6. US 12247978

    Compositions and methods for detection and treatment of coronavirus infection

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  7. US 12247973

    Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  8. US 12246011

    Radiation mitigator and method of use thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  9. US 12246012

    Method for treating nervous system injuries using boldine and derivatives thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  10. US 12247226

    Cellular reprogramming using temporal and transient plasmid vector expression system

    Fate Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  11. US 12247206

    Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  12. US 12246057

    Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  13. US 12247213

    Treatment of mucopolysaccharidosis IVA

    REGENXBIO INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  14. US 12247025

    Processes for preparation of soluble guanylate cyclase stimulators

    Cyclerion Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  15. US 12247059

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  16. US 12247052

    CpG amphiphiles and uses thereof

    Elicio Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  17. US 12247004

    2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use

    Oxford Drug Design Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  18. US 12246064

    Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  19. US 12246096

    Self-assembled microcapsules with stimuli-responsive organic ligands

    The Regents of the University of California · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  20. US 12247201

    Materials and methods for treatment of autosomal dominant retinitis pigmentosa

    CRISPR THERAPEUTICS AG · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  21. US 12246086

    Applications and imaging of shear-thinning biomaterial

    The Regents of the University of California · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  22. US 12247021

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  23. US 12246092

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  24. US 12247245

    Selectivity screening for antimicrobial compounds

    Northwestern University · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.